These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22303743)

  • 1. [Urology in 2011].
    Jichlinski P
    Rev Med Suisse; 2012 Jan; 8(323):61-3. PubMed ID: 22303743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.
    Sausville J; Naslund M
    Int J Clin Pract; 2010 Dec; 64(13):1740-5. PubMed ID: 21070524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Update on current care guidelines: benign prostatic hyperplasia].
    Tammela T; Nurmi M; Pétas A; Sipilä R; Taari K
    Duodecim; 2012; 128(10):1046-7. PubMed ID: 22724320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.
    Sarma AV; Wei JT
    N Engl J Med; 2012 Jul; 367(3):248-57. PubMed ID: 22808960
    [No Abstract]   [Full Text] [Related]  

  • 5. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current issues and reported findings from the National Survey on Benign Prostatic Hyperplasia.
    Fawzy A
    Int J Clin Pract Suppl; 2001 Sep; (122):2-22. PubMed ID: 11695085
    [No Abstract]   [Full Text] [Related]  

  • 7. A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines.
    Cornu JN; Cussenot O; Haab F; Lukacs B
    Eur Urol; 2010 Sep; 58(3):450-6. PubMed ID: 20554374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New international guidelines for treatment of uncomplicated, acute bacterial cystitis and pyelonephritis in women].
    Høiby N
    Ugeskr Laeger; 2000 Feb; 162(7):942. PubMed ID: 10740439
    [No Abstract]   [Full Text] [Related]  

  • 9. [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].
    Höfner K; Bach T; Berges R; Dreikorn K; Gratzke C; Madersbacher S; Michel MS; Muschter R; Oelke M; Reich O; Tschuschke C; Bschleipfer T
    Urologe A; 2016 Feb; 55(2):184-94. PubMed ID: 26518303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
    Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in International Prostate Symptom storage subscore after long-term medical therapy in BPH patients: finasteride and alpha-blocker combination therapy in men with moderate-to-severe LUTS/BPH in Korea.
    Lee JY; Lee SH; Kim SJ; Kim CS; Lee HM; Kim CI; Chung BH
    Urology; 2011 Jan; 77(1):171-6. PubMed ID: 20691464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of prostatic diseases.
    Schlegel PN
    Adv Intern Med; 1994; 39():569-601. PubMed ID: 7511322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management.
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():14-9. PubMed ID: 21501546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign prostatic hyperplasia. The Saudi perspective in the year 2000.
    Mosli HA; Atwa MA; Mahassini SH
    Saudi Med J; 2000 Oct; 21(10):915-20. PubMed ID: 11369951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy for prostate cancer.
    Berry WR
    N C Med J; 2006; 67(2):154-7. PubMed ID: 16752722
    [No Abstract]   [Full Text] [Related]  

  • 16. [Up-to-date on the treatment of benign prostatic hyperplasia. Which adenoma to treat and how to do it?].
    Lahlaidi K; Ariane MM; Fontaine E
    Rev Med Interne; 2014 Mar; 35(3):189-95. PubMed ID: 24262410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising the medical management of benign prostatic hyperplasia.
    Marberger M; Harkaway R; de la Rosette J
    Eur Urol; 2004 Apr; 45(4):411-9. PubMed ID: 15041103
    [No Abstract]   [Full Text] [Related]  

  • 18. Benign prostatic hyperplasia: current clinical practice.
    Djavan B; Eckersberger E; Finkelstein J; Espinosa G; Sadri H; Brandner R; Shah O; Lepor H
    Prim Care; 2010 Sep; 37(3):583-97, ix. PubMed ID: 20705200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey conducted on patients' and urologists' perceptions of benign prostatic hyperplasia.
    Kim SI; Kang JY; Lee HW; Seong do H; Cho JS
    Urol Int; 2011; 86(3):278-83. PubMed ID: 21273763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for benign prostatic hyperplasia (BPH) treatment.
    Emberton M; Fitzpatrick JM; Rees J
    BJU Int; 2011 Mar; 107(6):876-80. PubMed ID: 21265993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.